Core Laboratories (CLB) Cash from Investing Activities (2022 - 2026)

Core Laboratories has reported Cash from Investing Activities for 5 years, with the latest figure at -$3.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 539.25% year-over-year to -$3.4 million; the trailing twelve-month figure through Mar 2026 stood at -$6.4 million (down 61.26% YoY), and the FY2025 full-year result was -$2.2 million, up 65.11% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$3.4 million, up from -$3.8 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $2.4 million in Q3 2025, with the low at -$3.8 million in Q4 2025.
• Historically, Cash from Investing Activities has averaged -$1.3 million across 5 years, with a median of -$1.7 million in 2024.
• Annual changes were most pronounced in 2025 — Cash from Investing Activities soared 587.37% — and 2026, when it slumped 539.25%.
• Core Laboratories' Cash from Investing Activities stood at $1.1 million in 2022, then plunged by 331.19% to -$2.4 million in 2023, then sank by 45.5% to -$3.6 million in 2024, then dropped by 5.42% to -$3.8 million in 2025, then gained by 9.62% to -$3.4 million in 2026.
• The last three Cash from Investing Activities figures came in at -$3.4 million (Q1 2026), -$3.8 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.